Panacea Life Sciences Holdings, Inc. Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss
Panacea Life Sciences Holdings, Inc. (PLSH) reported Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss of $376 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-06.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2024-05-06
- Panacea Life Sciences Holdings, Inc. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2024-03-31 was $376.00.
| Period end | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 3 month |
|---|---|
| 2024-03-31 | $376.00 10-Q · filed 2024-05-06 |